UNSPSC 51386611: Hydrocortisone/salicylic acid/sulfur

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE200. This VA Drug Class (DE200) classifies this compound as belonging to the group ANTI-INFLAMMATORY, TOPICAL.

UNSPSC 51386611 Hydrocortisone/salicylic acid/sulfur is a Commodity code, but the recent state and local opportunities posted under it are unrelated to dermatological preparations — they involve naloxone procurement, direct-to-manufacturer pharmacy initiatives, and generic pharmaceutical distribution through cooperative purchasing. The code shows little relevant recent activity aligned with its nominal scope of topical dermatological agents.

The three recent opportunities reflect broader pharmaceutical and health-product procurement activity across state and local jurisdictions but do not target the specific product family named in the code. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives, with a July 26, 2023 response deadline and quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to serve participating state and local facilities across Minnesota and Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The MMCAP procurement emphasizes price competitiveness (75 percent evaluation weight) and requires vendors to maintain relationships with authorized wholesalers including AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC. Activity under this code does not align with hydrocortisone/salicylic acid/sulfur topical treatments and should be disregarded for business development purposes in that product line.